{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:34:23Z","timestamp":1792614863804,"version":"4.5.0"},"reference-count":42,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pathologic hypogonadism occurs when serum testosterone is significantly and persistently reduced by irreversible organic (structural, genetic) disorders of the hypothalamic pituitary testicular axis. Men with pathologic hypogonadism require lifelong testosterone replacement. In contrast, mild or moderate reductions in serum testosterone frequently accompany obesity, and its numerous comorbidities in men are best considered nongonadal illness syndromes, wherein reduction in serum testosterone is usually reversible upon amelioration of the underlying nongonadal illness.<\/jats:p>\n               <jats:p>Obesity can result in nonspecific symptoms in conjunction with reduced serum testosterone and serum SHBG. Obesity-related reductions in SHBG, testosterone's principal circulating carrier protein, are primarily responsible for measured reductions in testosterone. However, obesity is not a cause of pathological hypogonadism, and proportionately reduced testosterone and SHBG concentrations accompanied by normal serum LH and FSH concentrations confirm a eugonadal state, best described as the pseudo-hypogonadism of obesity.<\/jats:p>\n               <jats:p>Herein we demonstrate how clinically significant weight loss substantially reverses obesity-related reductions in serum testosterone and ameliorates nonspecific symptoms resembling, but not due to, androgen deficiency. The important reversible steps include weight reduction and optimizing management of type 2 diabetes mellitus, obstructive sleep apnea, depression, and other obesity-related comorbidities as well as rationalizing concomitant drug regimens. In the absence of pathological hypogonadism, testosterone treatment is less effective than a diet and lifestyle intervention to rectify the reversible conditions responsible for the nonspecific symptoms and associated reduced serum testosterone concentrations observed in men with obesity. As such, testosterone treatment is not indicated, and unwarranted off-label testosterone treatment can lead to adverse effects such as infertility, elevated hematocrit requiring venesection, a prothrombotic state, and testosterone dependence.<\/jats:p>","DOI":"10.1210\/clinem\/dgaf137","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T06:04:02Z","timestamp":1741327442000},"page":"e3125-e3130","source":"Crossref","is-referenced-by-count":21,"title":["Approach to the Patient: Low Testosterone Concentrations in Men With Obesity"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1430-0499","authenticated-orcid":false,"given":"Christopher A","family":"Muir","sequence":"first","affiliation":[{"name":"Department of Andrology, Concord Repatriation General Hospital , Sydney, NSW 2139 ,","place":["Australia"]},{"name":"Faculty of Medicine and Health, University of Sydney , Sydney, NSW 2050 ,","place":["Australia"]},{"name":"School of Clinical Medicine, University of New South Wales , Sydney, NSW 2052 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6818-6065","authenticated-orcid":false,"given":"Gary A","family":"Wittert","sequence":"additional","affiliation":[{"name":"South Australian Health and Medical Research Institute , Adelaide, SA 5000 ,","place":["Australia"]},{"name":"Freemasons Centre for Male Health and Wellbeing, University of Adelaide , Adelaide, SA 5000 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Handelsman","sequence":"additional","affiliation":[{"name":"Department of Andrology, Concord Repatriation General Hospital , Sydney, NSW 2139 ,","place":["Australia"]},{"name":"ANZAC Research Institute, University of Sydney , Sydney, NSW 2138 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"7","key":"2025081215524927900_dgaf137-B1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/obr.12282","article-title":"Testosterone and obesity","volume":"16","author":"Kelly","year":"2015","journal-title":"Obes Rev"},{"issue":"4","key":"2025081215524927900_dgaf137-B2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/endrev\/bnab001","article-title":"Androgen misuse and abuse","volume":"42","author":"Handelsman","year":"2021","journal-title":"Endocr Rev"},{"issue":"7","key":"2025081215524927900_dgaf137-B3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"2025081215524927900_dgaf137-B4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-8587(20)30367-3","article-title":"Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial","volume":"9","author":"Wittert","year":"2021","journal-title":"Lancet Diab Endocrinol"},{"issue":"2","key":"2025081215524927900_dgaf137-B5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"2025081215524927900_dgaf137-B6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1514009","article-title":"Mechanisms, pathophysiology, and management of obesity","volume":"376","author":"Heymsfield","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"2025081215524927900_dgaf137-B7","first-page":"643","article-title":"Obesity, body fat distribution and sex hormones in men","volume":"17","author":"Haffner","year":"1993","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"1","key":"2025081215524927900_dgaf137-B8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cen.13723","article-title":"Hypogonadism and male obesity: focus on unresolved questions","volume":"89","author":"Grossmann","year":"2018","journal-title":"Clin Endocrinol"},{"issue":"8","key":"2025081215524927900_dgaf137-B9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.5694\/mja13.10111","article-title":"Global trends in testosterone prescribing, 2000\u20132011: expanding the spectrum of prescription drug misuse","volume":"199","author":"Handelsman","year":"2013","journal-title":"Med J Aust"},{"issue":"2","key":"2025081215524927900_dgaf137-B10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.mce.2009.06.007","article-title":"Obesity and testicular function","volume":"316","author":"Mah","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2025081215524927900_dgaf137-B11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jcem.87.2.8299","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025081215524927900_dgaf137-B12","first-page":"3979","article-title":"Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone\u2013binding globulin gene","volume":"117","author":"Selva","year":"2007","journal-title":"J Clin Invest"},{"issue":"5","key":"2025081215524927900_dgaf137-B13","first-page":"1140","article-title":"Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men","volume":"76","author":"Vermeulen","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025081215524927900_dgaf137-B14","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1210\/jc.2018-00739","article-title":"IL-1 antagonism in men with metabolic syndrome and low testosterone: a randomized clinical trial","volume":"103","author":"Ebrahimi","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2025081215524927900_dgaf137-B15","doi-asserted-by":"crossref","first-page":"155290","DOI":"10.1016\/j.metabol.2022.155290","article-title":"Metformin, testosterone, or both in men with obesity and low testosterone: a double-blind, parallel-group, randomized controlled trial","volume":"136","author":"Fern\u00e1ndez-Garc\u00eda","year":"2022","journal-title":"Metabolism"},{"issue":"6","key":"2025081215524927900_dgaf137-B16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"2025081215524927900_dgaf137-B17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025081215524927900_dgaf137-B18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1185\/03007995.2015.1118023","article-title":"Monitoring testosterone levels in testosterone-treated men","volume":"32","author":"Winters","year":"2016","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"2025081215524927900_dgaf137-B19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MED.0000000000000891","article-title":"Use of calculated free testosterone in men: advantages and limitations","volume":"31","author":"Nyamaah","year":"2024","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"2025081215524927900_dgaf137-B20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/er.2017-00171","article-title":"Free testosterone: pumping up the tires or ending the free ride?","volume":"38","author":"Handelsman","year":"2017","journal-title":"Endocr Rev"},{"issue":"2","key":"2025081215524927900_dgaf137-B21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/andr.13111","article-title":"Association between obstructive sleep apnea and male serum testosterone: a systematic review and meta-analysis","volume":"10","author":"Su","year":"2022","journal-title":"Andrology"},{"issue":"2","key":"2025081215524927900_dgaf137-B22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1210\/jcem-68-2-352","article-title":"Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy","volume":"68","author":"Grunstein","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2025081215524927900_dgaf137-B23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3389\/fendo.2019.00551","article-title":"Effects of CPAP on testosterone levels in patients with obstructive sleep apnea: a meta-analysis study","volume":"10","author":"Cignarelli","year":"2019","journal-title":"Front Endocrinol"},{"issue":"1","key":"2025081215524927900_dgaf137-B24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1530\/EJE-19-0978","article-title":"Obstructive sleep apnea is not an independent determinant of testosterone in men","volume":"183","author":"Clarke","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025081215524927900_dgaf137-B25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/cen.12401","article-title":"Effect of continuous positive airway pressure therapy on sexual function and serum testosterone in males with type 2 diabetes and obstructive sleep apnoea","volume":"81","author":"Knapp","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"2","key":"2025081215524927900_dgaf137-B26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/andr.13484","article-title":"Meta-analysis and construction of simple-to-use nomograms for approximating testosterone levels gained from weight loss in obese men","volume":"12","author":"Ken-Dror","year":"2024","journal-title":"Andrology"},{"issue":"8","key":"2025081215524927900_dgaf137-B27","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1210\/jc.2011-0118","article-title":"Low testosterone in men with type 2 diabetes: significance and treatment","volume":"96","author":"Grossmann","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025081215524927900_dgaf137-B28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/andr.13318","article-title":"Effects of treatment for diabetes mellitus on testosterone concentrations: a systematic review","volume":"11","author":"Van Cauwenberghe","year":"2023","journal-title":"Andrology"},{"issue":"9","key":"2025081215524927900_dgaf137-B29","doi-asserted-by":"crossref","first-page":"e871","DOI":"10.1210\/clinem\/dgad180","article-title":"Approach to the patient: the evaluation and management of men \u226550 years with low serum testosterone concentration","volume":"108","author":"Grossmann","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025081215524927900_dgaf137-B30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1365-2265.2012.04432.x","article-title":"Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study","volume":"77","author":"Sartorius","year":"2012","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2025081215524927900_dgaf137-B31","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-19-0893","article-title":"European Society of Endocrinology clinical practice guideline: endocrine work-up in obesity","volume":"182","author":"Pasquali","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025081215524927900_dgaf137-B32","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1530\/EJE-12-0955","article-title":"Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis","volume":"168","author":"Corona","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2025081215524927900_dgaf137-B33","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.3390\/nu11122975","article-title":"The role of diet and weight loss in improving secondary hypogonadism in men with obesity with or without type 2 diabetes mellitus","volume":"11","author":"Giagulli","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"2025081215524927900_dgaf137-B34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1462-8902.2004.00335.x","article-title":"Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome","volume":"6","author":"Niskanen","year":"2004","journal-title":"Diab Obes Metab"},{"issue":"4","key":"2025081215524927900_dgaf137-B35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00007256-200535040-00004","article-title":"Hormonal responses and adaptations to resistance exercise and training","volume":"35","author":"Kraemer","year":"2005","journal-title":"Sports Med"},{"key":"2025081215524927900_dgaf137-B36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3389\/fendo.2018.00769","article-title":"Obesity, male reproductive function and bariatric surgery","volume":"9","author":"Di Vincenzo","year":"2018","journal-title":"Front Endocrinol"},{"issue":"12","key":"2025081215524927900_dgaf137-B37","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1007\/s11695-020-04851-3","article-title":"Bariatric surgery impact on reproductive hormones, semen analysis, and sperm DNA fragmentation in men with severe obesity: prospective study","volume":"30","author":"Wood","year":"2020","journal-title":"Obes Surg"},{"issue":"4","key":"2025081215524927900_dgaf137-B38","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s11695-022-05901-8","article-title":"Bariatric surgery does not improve semen quality: evidence from a meta-analysis","volume":"32","author":"Gao","year":"2022","journal-title":"Obes Surg"},{"key":"2025081215524927900_dgaf137-B39","doi-asserted-by":"crossref","first-page":"821113","DOI":"10.3389\/fendo.2022.821113","article-title":"The effects of the new therapeutic treatments for diabetes mellitus on the male reproductive axis","volume":"13","author":"Pelusi","year":"2022","journal-title":"Front Endocrinol"},{"issue":"8","key":"2025081215524927900_dgaf137-B40","doi-asserted-by":"crossref","first-page":"e0161208","DOI":"10.1371\/journal.pone.0161208","article-title":"Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: a case-control study","volume":"11","author":"Rasmussen","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"2025081215524927900_dgaf137-B41","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1210\/clinem\/dgz324","article-title":"Rate and extent of recovery from reproductive and cardiac dysfunction due to androgen abuse in men","volume":"105","author":"Shankara-Narayana","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025081215524927900_dgaf137-B42","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1210\/clinem\/dgad485","article-title":"Long-term outcomes of testosterone treatment in men: a T4DM postrandomization observational follow-up study","volume":"109","author":"Handelsman","year":"2023","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf137\/62310606\/dgaf137.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/9\/e3125\/62310606\/dgaf137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/9\/e3125\/62310606\/dgaf137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T19:53:04Z","timestamp":1755028384000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/9\/e3125\/8058933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":42,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,3,7]]},"published-print":{"date-parts":[[2025,8,7]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf137","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,3,7]]}}}